Daniel Gesua Sive Salvadori Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Daniel Gesua Sive Salvadori.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Daniel Gesua Sive Salvadori. Daniel Gesua Sive Salvadori is Executive Vice President in ABBOTT LABORATORIES ($ABT) and Senior Vice President in ABBOTT LABORATORIES ($ABT).
Latest Insider Trading Transactions of Daniel Gesua Sive Salvadori
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Feb 23 2021 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRES ... | Option Exercise | A | 124.04 | 98,708 | 12,243,740 | 98,708 | |
Feb 23 2021 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | EXECUTIVE VICE PRES ... | Grant | A | 0.00 | 19,257 | 0 | 121,690 | 102.4 K to 121.7 K (+18.80 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 42,479 | 1,996,513 | 0 | |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 111.86 | 42,479 | 4,751,701 | 102,433 | 144.9 K to 102.4 K (-29.31 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 42,479 | 1,996,513 | 144,912 | 102.4 K to 144.9 K (+41.47 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 42,479 | 1,996,513 | 0 | |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 111.86 | 42,479 | 4,751,701 | 102,433 | 144.9 K to 102.4 K (-29.31 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 42,479 | 1,996,513 | 144,912 | 102.4 K to 144.9 K (+41.47 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 42,479 | 1,996,513 | 0 | |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 111.86 | 42,479 | 4,751,701 | 102,433 | 144.9 K to 102.4 K (-29.31 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 42,479 | 1,996,513 | 144,912 | 102.4 K to 144.9 K (+41.47 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 42,479 | 1,996,513 | 0 | |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 111.86 | 42,479 | 4,751,701 | 102,433 | 144.9 K to 102.4 K (-29.31 %) |
Aug 31 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 42,479 | 1,996,513 | 144,912 | 102.4 K to 144.9 K (+41.47 %) |
Jul 23 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Payment of Exercise | F | 99.08 | 1,060 | 105,025 | 102,433 | 103.5 K to 102.4 K (-1.02 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 77.89 | 999 | 77,812 | 103,493 | 104.5 K to 103.5 K (-0.96 %) |
Mar 03 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Payment of Exercise | F | 79.19 | 12,279 | 972,374 | 104,492 | 116.8 K to 104.5 K (-10.52 %) |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | A | 87.72 | 132,182 | 11,595,005 | 132,182 | |
Feb 25 2020 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Grant | A | 0.00 | 21,683 | 0 | 116,771 | 95.1 K to 116.8 K (+22.80 %) |
Jul 23 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Payment of Exercise | F | 87.49 | 1,060 | 92,739 | 95,088 | 96.1 K to 95.1 K (-1.10 %) |
Jun 27 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 38.40 | 71,000 | 2,726,400 | 71,313 | |
Jun 27 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 84.00 | 71,000 | 5,964,007 | 96,148 | 167.1 K to 96.1 K (-42.48 %) |
Jun 27 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 38.40 | 71,000 | 2,726,400 | 167,148 | 96.1 K to 167.1 K (+73.84 %) |
Jun 13 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 82.00 | 3,331 | 273,142 | 96,148 | 99.5 K to 96.1 K (-3.35 %) |
Jun 13 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 82.00 | 7,269 | 596,058 | 99,479 | 106.7 K to 99.5 K (-6.81 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 78.00 | 1,664 | 129,792 | 106,748 | 108.4 K to 106.7 K (-1.53 %) |
Mar 04 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Payment of Exercise | F | 77.23 | 11,097 | 857,021 | 108,412 | 119.5 K to 108.4 K (-9.29 %) |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | A | 75.90 | 162,430 | 12,328,437 | 162,430 | |
Feb 26 2019 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Grant | A | 0.00 | 30,988 | 0 | 119,509 | 88.5 K to 119.5 K (+35.01 %) |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 73.39 | 4,800 | 352,277 | 88,521 | 93.3 K to 88.5 K (-5.14 %) |
Oct 02 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 73.40 | 200 | 14,680 | 93,321 | 93.5 K to 93.3 K (-0.21 %) |
Jul 24 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Payment of Exercise | F | 63.32 | 1,060 | 67,119 | 93,521 | 94.6 K to 93.5 K (-1.12 %) |
May 21 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 61.50 | 1,000 | 61,500 | 94,581 | 95.6 K to 94.6 K (-1.05 %) |
May 21 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 61.05 | 2,000 | 122,092 | 95,581 | 97.6 K to 95.6 K (-2.05 %) |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | A | 59.94 | 182,935 | 10,965,124 | 182,935 | |
Feb 21 2018 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Grant | A | 0.00 | 33,266 | 0 | 107,064 | 73.8 K to 107.1 K (+45.08 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 28,319 | 1,330,993 | 42,479 | |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 54.94 | 7,700 | 423,000 | 73,798 | 81.5 K to 73.8 K (-9.45 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 54.93 | 6,897 | 378,852 | 81,498 | 88.4 K to 81.5 K (-7.80 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 54.92 | 100 | 5,492 | 88,395 | 88.5 K to 88.4 K (-0.11 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 54.92 | 1,900 | 104,348 | 88,495 | 90.4 K to 88.5 K (-2.10 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 54.92 | 200 | 10,983 | 90,395 | 90.6 K to 90.4 K (-0.22 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 54.91 | 200 | 10,982 | 90,595 | 90.8 K to 90.6 K (-0.22 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 54.91 | 1,483 | 81,432 | 90,795 | 92.3 K to 90.8 K (-1.61 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 54.90 | 9,839 | 540,171 | 92,278 | 102.1 K to 92.3 K (-9.64 %) |
Dec 14 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 28,319 | 1,330,993 | 102,117 | 73.8 K to 102.1 K (+38.37 %) |
Nov 16 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 38.40 | 71,157 | 2,732,429 | 142,313 | |
Nov 16 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 55.00 | 71,157 | 3,913,635 | 73,798 | 145 K to 73.8 K (-49.09 %) |
Nov 16 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 38.40 | 71,157 | 2,732,429 | 144,955 | 73.8 K to 145 K (+96.42 %) |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 47.00 | 28,319 | 1,330,993 | 70,798 | |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 42.08 | 34,142 | 1,436,695 | 0 | |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Option Exercise | M | 42.08 | 34,142 | 1,436,695 | 34,142 | |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Sell | S | 56.21 | 96,603 | 5,430,055 | 73,798 | 170.4 K to 73.8 K (-56.69 %) |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 47.00 | 28,319 | 1,330,993 | 170,401 | 142.1 K to 170.4 K (+19.93 %) |
Oct 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Executive Vice Pres ... | Buy | M | 42.08 | 68,284 | 2,873,391 | 142,082 | 73.8 K to 142.1 K (+92.53 %) |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | M | 47.00 | 28,319 | 1,330,993 | 99,117 | |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | M | 42.08 | 34,141 | 1,436,653 | 68,284 | |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Payment of Exercise | F | 52.61 | 5,487 | 288,671 | 73,798 | 79.3 K to 73.8 K (-6.92 %) |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 52.95 | 62,460 | 3,307,257 | 79,285 | 141.7 K to 79.3 K (-44.07 %) |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Buy | M | 47.00 | 28,319 | 1,330,993 | 141,745 | 113.4 K to 141.7 K (+24.97 %) |
Sep 28 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Buy | M | 42.08 | 34,141 | 1,436,653 | 113,426 | 79.3 K to 113.4 K (+43.06 %) |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | A | 50.72 | 49,611 | 2,516,270 | 49,611 | |
Jul 25 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Grant | A | 0.00 | 7,173 | 0 | 79,285 | 72.1 K to 79.3 K (+9.95 %) |
Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 45.39 | 2,066 | 93,776 | 72,112 | 74.2 K to 72.1 K (-2.79 %) |
Mar 02 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Payment of Exercise | F | 45.46 | 4,759 | 216,344 | 74,178 | 78.9 K to 74.2 K (-6.03 %) |
Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | A | 44.40 | 138,049 | 6,129,376 | 138,049 | |
Feb 22 2017 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Grant | A | 0.00 | 19,961 | 0 | 78,937 | 59 K to 78.9 K (+33.85 %) |
Sep 28 2016 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 41.71 | 815 | 33,994 | 58,976 | 59.8 K to 59 K (-1.36 %) |
Sep 28 2016 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Payment of Exercise | F | 42.19 | 2,001 | 84,422 | 59,791 | 61.8 K to 59.8 K (-3.24 %) |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 39.27 | 100 | 3,927 | 61,792 | 61.9 K to 61.8 K (-0.16 %) |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 39.26 | 81 | 3,180 | 61,892 | 62 K to 61.9 K (-0.13 %) |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 39.26 | 700 | 27,483 | 61,973 | 62.7 K to 62 K (-1.12 %) |
Mar 02 2016 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Payment of Exercise | F | 39.52 | 1,649 | 65,168 | 62,673 | 64.3 K to 62.7 K (-2.56 %) |
Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | A | 38.40 | 213,470 | 8,197,248 | 213,470 | |
Feb 23 2016 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Grant | A | 0.00 | 24,348 | 0 | 64,322 | 40 K to 64.3 K (+60.91 %) |
Sep 29 2015 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 39.65 | 715 | 28,348 | 39,974 | 40.7 K to 40 K (-1.76 %) |
Sep 29 2015 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Sell | S | 39.64 | 100 | 3,964 | 40,689 | 40.8 K to 40.7 K (-0.25 %) |
Sep 29 2015 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Payment of Exercise | F | 40.86 | 1,526 | 62,352 | 40,789 | 42.3 K to 40.8 K (-3.61 %) |
Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | A | 47.00 | 127,436 | 5,989,492 | 127,436 | |
Feb 24 2015 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Grant | A | 0.00 | 18,085 | 0 | 42,315 | 24.2 K to 42.3 K (+74.64 %) |
Sep 30 2014 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Option Exercise | A | 42.08 | 102,425 | 4,310,044 | 102,425 | |
Sep 30 2014 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Grant | A | 0.00 | 7,500 | 0 | 24,230 | 16.7 K to 24.2 K (+44.83 %) |
Sep 30 2014 | ABT | ABBOTT LABORATORIE ... | Salvadori Daniel Gesua Sive | Senior Vice Preside ... | Grant | A | 0.00 | 16,730 | 0 | 16,730 | 0 to 16.7 K |
Page: 1